Healthcare
Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026
Company to highlight therapy’s use at leading pediatric continuous renal replacement therapy educational conferenceMINNEAPOLIS, July 07, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces its participation in the KidneyBee Summit 2026, taking place July 14-16, 2026, at Children's Hospital Colorado in Aurora, Colorado. As part of its participation, Nuwellis will engage with conf
About this update from Nuwellis, Inc.
Company to highlight therapy's use at leading pediatric continuous renal replacement therapy educational conference MINNEAPOLIS, July 07, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces its participation in the KidneyBee Summit 2026, taking place July 14-16, 2026, at Children's Hospital Colorado in Aurora, Colorado. As part of its participation, Nuwellis will engage with conference attendees to discuss the role of precise fluid management in pediatric patients with acute kidney injury, cardiorenal conditions, and fluid overload. The Company will highlight the Aquadex SmartFlow® System, which enables controlled, predictable fluid removal and is increasingly being utilized at leading pediatric centers across the U.S. "Education and collaboration are essential to advancing care for critically ill pediatric patients," said Nuwellis' CEO Mike McCormick. "The KidneyBee Summit brings together many of the nation's leading pediatric nephrology experts to share knowledge and best practices and we look forward to this educational opportunity. As our pediatric presence continues to expand, opportunities like KidneyBee allow us to engage directly with clinicians who are committed to improving outcomes for children requiring advanced fluid management." The KidneyBee Summit is hosted by Children's Hospital Colorado and features contributing faculty from several leading pediatric centers. The event brings together pediatric nephrology, critical care, nursing, and advanced practice providers from leading children's hospitals across the country. It features expert-led education, hands-on learning, high-fidelity simulation, and collaborative discussions focused on advancing the science and practice of pediatric CRRT. Nuwellis continues to expand its presence within pediatric critical care, where clinicians increasingly recognize the importance of precise, controlled ultrafiltration for managing fluid overload. The Company's growing pediatric category reflects its broader strategy to advance care across the heart-kidney continuum through innovative technologies that address unmet clinical needs. Additional information about the KidneyBee Summit 2026 can be found at the event's website . About Nuwellis Nuwellis, Inc. (Nasdaq: NUWE) is a medical technology company committed to delivering solutions for patients with cardiorenal conditions. The Company develops solutions designed to support patient care through monitoring, therapy, and data-informed clinical decision-making across acute and chronic care settings. Nuwellis' portfolio includes commercially available and development-stage technologies addressing complex cardiorenal conditions, with a focus on safety, precision, and scalability across patient populations. For more information, visit www.nuwellis.com .